Aligos Therapeutics, Inc. — All Filings
325 total filings on record
Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.
All
10-K
10-Q
3
4
424B3
424B4
8-A12B
8-K
8-K/A
ARS
CERT
CORRESP
D
DEF 14A
DEFA14A
DEFR14A
DRS
EFFECT
PRE 14A
S-1
S-1/A
S-3
S-8
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SC TO-C
SC TO-I
SC TO-I/A
SCHEDULE 13D/A
SCHEDULE 13G
SCHEDULE 13G/A
SEC STAFF LETTER
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| 4 | — | 0001610717-25-000045 | Mar 4, 2025 | Feb 28, 2025 |
| D | — | 0000950123-25-002925 | Feb 28, 2025 | — |
| SCHEDULE 13G/A | — | 0001172661-25-001230 | Feb 14, 2025 | — |
| SCHEDULE 13G/A | — | 0000902664-25-000862 | Feb 12, 2025 | — |
| 8-K | 8-K | 0001193125-25-024838 | Feb 12, 2025 | Feb 11, 2025 |
| 8-K | 8-K | 0001193125-25-019256 | Feb 3, 2025 | Jan 30, 2025 |
| EFFECT | — | 9999999995-24-003508 | Nov 18, 2024 | — |
| SC 13G/A | ALIGOS THERAPEUTICS, INC. | 0000902664-24-006624 | Nov 14, 2024 | — |
| SC 13G/A | — | 0001172661-24-005266 | Nov 14, 2024 | — |
| SC 13G/A | — | 0001172661-24-005305 | Nov 14, 2024 | — |
| SC 13G/A | — | 0000935836-24-000723 | Nov 14, 2024 | — |
| CORRESP | — | 0001193125-24-258591 | Nov 14, 2024 | — |
| SC 13G/A | AMENDMENT NO. 1 TO SCHEDULE 13G | 0001213900-24-098622 | Nov 14, 2024 | — |
| UPLOAD | — | 0000000000-24-012567 | Nov 13, 2024 | — |
| SC 13G | ALIGOS THERAPEUTICS, INC. | 0000902664-24-006398 | Nov 12, 2024 | — |
| S-8 | S-8 | 0001193125-24-252201 | Nov 6, 2024 | — |
| 8-K | FORM 8-K | 0001171843-24-006057 | Nov 6, 2024 | — |
| 10-Q | 10-Q | 0000950170-24-122371 | Nov 6, 2024 | Sep 30, 2024 |
| S-3 | S-3 | 0001193125-24-252199 | Nov 6, 2024 | — |
| 4 | — | 0001610717-24-000503 | Oct 10, 2024 | Oct 8, 2024 |
| 3 | — | 0001610717-24-000495 | Sep 26, 2024 | Sep 23, 2024 |
| SC 13G | — | 0001783647-24-000001 | Sep 12, 2024 | — |
| 4 | — | 0001610717-24-000465 | Sep 6, 2024 | Sep 4, 2024 |
| 4 | — | 0001610717-24-000466 | Sep 6, 2024 | Sep 4, 2024 |
| 4 | — | 0001610717-24-000464 | Sep 6, 2024 | Sep 4, 2024 |
| 8-K | 8-K | 0001193125-24-214188 | Sep 5, 2024 | Sep 3, 2024 |
| 8-K | 8-K | 0001193125-24-202813 | Aug 19, 2024 | Aug 14, 2024 |
| 4 | — | 0001610717-24-000423 | Aug 9, 2024 | Aug 7, 2024 |
| 4 | — | 0001610717-24-000422 | Aug 9, 2024 | Aug 7, 2024 |
| 3 | — | 0001610717-24-000419 | Aug 9, 2024 | Aug 7, 2024 |
| 3 | — | 0001610717-24-000421 | Aug 9, 2024 | Aug 7, 2024 |
| 8-K | 8-K | 0001193125-24-196966 | Aug 8, 2024 | Aug 7, 2024 |
| 8-K | FORM 8-K | 0001171843-24-004482 | Aug 6, 2024 | — |
| 10-Q | 10-Q | 0000950170-24-091828 | Aug 6, 2024 | Jun 30, 2024 |
| 4 | — | 0001610717-24-000372 | Jun 28, 2024 | Jun 27, 2024 |
| 4 | — | 0001610717-24-000371 | Jun 28, 2024 | Jun 27, 2024 |
| 8-K | 8-K | 0001193125-24-172218 | Jun 28, 2024 | Jun 27, 2024 |
| 4 | — | 0001610717-24-000369 | Jun 28, 2024 | Jun 27, 2024 |
| 4 | — | 0001610717-24-000370 | Jun 28, 2024 | Jun 27, 2024 |
| 8-K | 8-K | 0001193125-24-151729 | May 31, 2024 | May 29, 2024 |
| 8-K | 8-K | 0001193125-24-144929 | May 22, 2024 | May 21, 2024 |
| 8-K | 8-K | 0001193125-24-139476 | May 15, 2024 | May 9, 2024 |
| 8-K | FORM 8-K | 0001171843-24-002612 | May 7, 2024 | — |
| 10-Q | 10-Q | 0000950170-24-054497 | May 7, 2024 | Mar 31, 2024 |
| DEFA14A | DEFA14A | 0001193125-24-122208 | Apr 29, 2024 | — |
| DEF 14A | DEF 14A | 0001193125-24-122181 | Apr 29, 2024 | Jun 27, 2024 |
| ARS | ARS | 0001193125-24-122248 | Apr 29, 2024 | Dec 31, 2023 |
| PRE 14A | PRE 14A | 0001193125-24-097951 | Apr 16, 2024 | Jun 27, 2024 |
| 10-K | 10-K | 0000950170-24-029953 | Mar 12, 2024 | Dec 31, 2023 |
| S-8 | S-8 | 0001193125-24-065970 | Mar 12, 2024 | — |